Skip to main content
Journal cover image

State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction.

Publication ,  Journal Article
Patel, MR; Meine, TJ; Radeva, J; Curtis, L; Rao, SV; Schulman, KA; Jollis, JG
Published in: J Am Coll Cardiol
July 7, 2004

OBJECTIVES: The purpose of this study was to determine whether state-mandated continuing medical education (CME) requirements affect the use of evidence-based therapies and outcomes in patients with acute myocardial infarction (AMI). BACKGROUND: The Institute of Medicine recommends that educational programs demonstrate their effect through process and outcome measures. METHODS: We analyzed 134,609 patients according to whether or not CME was mandated in the state of physician practice. A hierarchical multivariable model was developed that controlled for state, hospital, physician, and patient level characteristics to determine the association between state CME requirements and the use of evidence-based therapies. Primary outcome measures were admission aspirin use and reperfusion therapy, and discharge aspirin and beta-blocker prescription. Thirty-day and one-year mortality were secondary outcome measures. RESULTS: States with and without CME requirements had similar rates of aspirin use at admission and discharge (79.9% vs. 79.4% and 72.5% vs. 72.5%, respectively) and beta-blocker prescription at discharge (53.6% vs. 55.3%). The rate of reperfusion therapy at admission was significantly higher in states requiring CME (53.1%) compared with states without CME (47.9%) (p < 0.0001). After adjustment, patients admitted in CME-requiring states were significantly more likely to receive reperfusion therapy, mainly owing to "patented" thrombolytic therapy (odds ratio 1.15; p = 0.016). There was no association between CME requirements and one-year mortality. CONCLUSIONS: State-mandated CME had little association with AMI care or outcome, other than an increased use of patented thrombolytic therapy. Further research is needed to maximize the measurable effect of CME on the use of proven therapies irrespective of whether patented or generic medications are involved.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

July 7, 2004

Volume

44

Issue

1

Start / End Page

192 / 198

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Thrombolytic Therapy
  • Survival Analysis
  • Statistics as Topic
  • Quality Indicators, Health Care
  • Program Evaluation
  • Practice Patterns, Physicians'
  • Patient Admission
  • Myocardial Infarction
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Patel, M. R., Meine, T. J., Radeva, J., Curtis, L., Rao, S. V., Schulman, K. A., & Jollis, J. G. (2004). State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction. J Am Coll Cardiol, 44(1), 192–198. https://doi.org/10.1016/j.jacc.2004.03.070
Patel, Manesh R., Trip J. Meine, Jasmina Radeva, Lesley Curtis, Sunil V. Rao, Kevin A. Schulman, and James G. Jollis. “State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction.J Am Coll Cardiol 44, no. 1 (July 7, 2004): 192–98. https://doi.org/10.1016/j.jacc.2004.03.070.
Patel MR, Meine TJ, Radeva J, Curtis L, Rao SV, Schulman KA, et al. State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction. J Am Coll Cardiol. 2004 Jul 7;44(1):192–8.
Patel, Manesh R., et al. “State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction.J Am Coll Cardiol, vol. 44, no. 1, July 2004, pp. 192–98. Pubmed, doi:10.1016/j.jacc.2004.03.070.
Patel MR, Meine TJ, Radeva J, Curtis L, Rao SV, Schulman KA, Jollis JG. State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction. J Am Coll Cardiol. 2004 Jul 7;44(1):192–198.
Journal cover image

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

July 7, 2004

Volume

44

Issue

1

Start / End Page

192 / 198

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Thrombolytic Therapy
  • Survival Analysis
  • Statistics as Topic
  • Quality Indicators, Health Care
  • Program Evaluation
  • Practice Patterns, Physicians'
  • Patient Admission
  • Myocardial Infarction